Inhibitors of p56Ick: Assessing their potential as tools for manipulating T-lymphocte activation

Expert Opinion on Therapeutic Patents

Volumn 11, Issue 2, 2001, Pages 295-306

  Dowden, J ^a   Ward, S G ^a  

^a UNIVERSITY OF BATH   (United Kingdom)

Author keywords

Indandiones; Isothiazolones; Natural products; P56lck; Pyrazolopyrimidines; Pyridopyrimidines; Quinazolines; SH2 domains; T lymphocytes; TCR

Indexed keywords

1 METHOXY AGROCLAVINE; 1,3 INDANDIONE DERIVATIVE; 2 ANILINOPYRIMIDINE DERIVATIVE; 3 DIMETHYLAMINO 1 PHENYL 6 PYRIDAZONE; 4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; A 125800; ADENOSINE TRIPHOSPHATE; AGROCLAVINE; BENZOTHIAZOLE DERIVATIVE; GENISTEIN; IMIDAZOLPYRAZINE DERIVATIVE; INDENOPYRAZOLE DERIVATIVE; ISOTHIAZOLONE DERIVATIVE; LYSERGOL; METHYL 3 (N ISOTHIAZALONE) 2 THIOPHENECARBOXYLIC ACID; NATURAL PRODUCT; PHOSPHOTYROSINE; PHTHALAMATE DERIVATIVE; PICEATANNOL; PROTEIN P56; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; PYRAZOLE DERIVATIVE; PYRAZOLOPYRIMIDINE DERIVATIVE; PYRIDO(2,3 DEXTRO)PYRIMIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; QUERCETIN; QUINAZOLINE DERIVATIVE; QUINOLINE DERIVATIVE; QUINOXALINE DERIVATIVE; STAUROSPORINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BINDING SITE; CELL MATURATION; CONTROLLED STUDY; COVALENT BOND; DOSE RESPONSE; DRUG ISOLATION; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; IC 50; MOUSE; NATURAL KILLER CELL; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; T LYMPHOCYTE ACTIVATION;

EID: 0035151006     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.11.2.295     Document Type: Review

References (29)

1. The role of protein-tyrosine kinases and protein-tyrosine phosphatases in T-cell antigen receptor signal-transduction
2. Signal transduction by lymphocyte antigen receptors
3. Genetic evidence for the involvement of the Lck tyrosine kinase in signal transduction through the T-cell antigen receptor
4. The Lck tyrosine protein-kinase interacts with the cytoplasmic tail of the CD4 glycoprotein through its unique amino-terminal domain
5. The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes
6. lck) that phosphorylates the CD3 complex
7. Hierarchy of protein tyrosine kinases in interleukin-2 (IL2) signalling: Activation of Syk depends on Jak3; however, neither Syk nor Lck is required for IL-2-mediated STAT activation
8. CD28: A signalling perspective
9. αβ T cell development is abolished in mice lacking both Lck and Fyn protein tyrosine kinases
10. HIV infection-induced post-translational modification of T cell signalling molecules associated with disease progression
11. lck tyrosine kinase by isothiazolones
12. A new bioactive sesterterpene and antiplasmodial alkaloids from the Marine Sponge Hyrtios cf. erecta
13. Ascosalipyrrolidinone A, an antimicrobial alkaloid, from the obligate marine fungus Ascochyta salicorniae
14. 1-methoxy-agroclavine from Penicillium sp. WC75209, a novel inhibitor of the Lck tyrosine kinase
15. lck tyrosine kinase inhibitors
16. lck and EGF-R tyrosine kinase activity
17. Biochemical and cellular effects of c-Src kinase-selective pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors
18. Discovery of a novel, potent and Src family-selective tyrosine kinase inhibitor: Study of Lck- and FynT-dependent T cell activation
19. Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors
20. Inhibitors of Src-family tyrosine kinases favour Th2 differentiation
21. Pyrrolo[2,3-d]pyrimidines containing an extended 5-substituent as potent and selective inhibitors of Lck (I)
22. Pyrrolo[2,3-d]pyrimidines containing an extended 5-substituent as potent and selective inhibitors of Lck (II)
23. lck SH2 domain
24. lck SH2 domain: Discovery of potent dipeptide derivatives with monocharged, nonhydrolyzable phosphate replacements
25. SH2-directed ligands of the Lck tyrosine kinase
26. Discovering high-affinity ligands for proteins: SAR by NMR
27. Drug design: Discovering high-affinity ligands for proteins
28. NMR-based discovery of phosphotyrosine mimetics that bind to the Lck SH2 domain
29. A chemical switch for inhibitor-sensitive alleles of any protein kinase